Resveratrol

Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a stilbenoid, a type of natural phenol, and a phytoalexin produced by several plants in response to injury or when the plant is under attack by pathogens, such as bacteria or fungi.[6][7] Sources of resveratrol in food include the skin of grapes, blueberries, raspberries, mulberries, and peanuts.[8][9]

Resveratrol

Chemical structures of cis- ((Z)-resveratrol, left) and trans-resveratrol ((E)-resveratrol, right)[1]
Names
Preferred IUPAC name
5-[(E)-2-(4-Hydroxyphenyl)ethen-1-yl]benzene-1,3-diol
Other names
trans-3,5,4′-Trihydroxystilbene;
3,4′,5-Stilbenetriol;
trans-Resveratrol;
(E)-5-(p-Hydroxystyryl)resorcinol;
(E)-5-(4-hydroxystyryl)benzene-1,3-diol
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.121.386
KEGG
RTECS number
  • CZ8987000
UNII
CompTox Dashboard (EPA)
  • InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ Y
    Key: LUKBXSAWLPMMSZ-OWOJBTEDSA-N Y
  • InChI=1/C14H12O3/c15-
    12-5-3-10(4-6-12)
    1-2-11-7-13(16)9-
    14(17)8-11/h1-9,15-
    17H/b2-1+
  • Oc1ccc(cc1)\C=C\c2cc(O)cc(O)c2
Properties
C14H12O3
Molar mass 228.247 g·mol−1
Appearance white powder with
slight yellow cast
Melting point 261 to 263 °C (502 to 505 °F; 534 to 536 K)[2]
Solubility in water 0.03 g/L
Solubility in DMSO 16 g/L
Solubility in ethanol 50 g/L
UV-vis (λmax) 304nm (trans-resveratrol, in water)
286nm (cis-resveratrol, in water)[1]
Hazards
GHS labelling:[3]
Warning
Hazard statements
 H319
Precautionary statements
 P264, P280, P305+P351+P338, P337+P313
Lethal dose or concentration (LD, LC):
23.2 μM (5.29 g)[4]
Safety data sheet (SDS) Fisher Scientific[2]
Sigma Aldrich[5]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y verify (what is YN ?)
Infobox references
UV visible spectrum of trans-resveratrol

Although commonly used as a dietary supplement and studied in laboratory models of human diseases,[10] there is no high-quality evidence that resveratrol improves lifespan or has a substantial effect on any human disease.[11][12][13]

Research

Resveratrol has been studied for its potential therapeutic use,[14] with little evidence of anti-disease effects or health benefits in humans.[6][10]

Cardiovascular disease

There is no evidence of benefit from resveratrol in people who already have heart disease.[10][15] A 2018 meta-analysis found no effect on systolic or diastolic blood pressure; a sub-analysis revealed a 2 mmHg decrease in systolic pressure only from resveratrol doses of 300 mg per day, and only in diabetic people.[16] A 2014 Chinese meta-analysis found no effect on systolic or diastolic blood pressure; a sub-analysis found an 11.90 mmHg reduction in systolic blood pressure from resveratrol doses of 150 mg per day.[17]

Cancer

As of 2020, there is no evidence of an effect of resveratrol on cancer in humans.[10][18]

Metabolic syndrome

There is no conclusive evidence for an effect of resveratrol on human metabolic syndrome.[10][19][20] One 2015 review found little evidence for use of resveratrol to treat diabetes.[21] A 2015 meta-analysis found little evidence for an effect of resveratrol on diabetes biomarkers.[22]

One review found limited evidence that resveratrol lowered fasting plasma glucose in people with diabetes.[23] Two reviews indicated that resveratrol supplementation may reduce body weight and body mass index, but not fat mass or total blood cholesterol.[24][25] A 2018 review found that resveratrol supplementation may reduce biomarkers of inflammation, TNF-α and C-reactive protein.[26]

Lifespan

There is insufficient evidence to indicate that consuming resveratrol has an effect on human lifespan.[11]

Cognition

Resveratrol has been assessed for a possible effect on cognition, but with mixed evidence for an effect. One review concluded that resveratrol had no effect on neurological function, but reported that supplementation improved recognition and mood, although there were inconsistencies in study designs and results.[27]

Diabetes

Although animal experiments have found some evidence that resveratrol may help improve insulin sensitivity and so potentially help manage diabetes, subsequent research on people is limited and does not support the use of resveratrol for this purpose.[28]

Other

There is no significant evidence that resveratrol affects vascular endothelial function, neuroinflammation, Alzheimer's disease, skin infections or aging skin.[6][10] A 2019 review of human studies found mixed effects of resveratrol on certain bone biomarkers, such as increases in blood and bone alkaline phosphatase, while reporting no effect on other biomarkers, such as calcium and collagen.[29]

Pharmacology

Pharmacodynamics

Resveratrol has been identified as a pan-assay interference compound, which produces positive results in many different laboratory assays.[30] Its ability for varied interactions may be due to direct effects on cell membranes.[31]

As of 2015, many specific biological targets for resveratrol had been identified, including NQO2 (alone and in interaction with AKT1), GSTP1, estrogen receptor beta, CBR1, and integrin αVβ. It was unclear at that time if any or all of these were responsible for the observed effects in cells and model organisms.[32]

Pharmacokinetics

The viability of an oral delivery method is unlikely due to the low aqueous solubility of the molecule. The bioavailability of resveratrol is about 0.5% due to extensive hepatic glucuronidation and sulfation.[33] Glucuronidation occurs in the intestine as well as in the liver, whereas sulfonation not only occurs in the liver but in the intestine and by microbial gut activity.[34] Due to rapid metabolism, the half-life of resveratrol is short (about 8–14 minutes), but the half-life of the sulphate and glucoronide metabolites is above 9 hours.[35]

Metabolism

Resveratrol is extensively metabolized in the body,[6] with the liver and intestines as the major sites of its metabolism.[36][35] Liver metabolites are products of phase II (conjugation) enzymes,[37] which are themselves induced by resveratrol in vitro.[38]

Chemistry

Resveratrol (3,5,4'-trihydroxystilbene) is a stilbenoid, a derivative of stilbene.[6] It exists as two geometric isomers: cis- (Z) and trans- (E), with the trans-isomer shown in the top image. Resveratrol exists conjugated to glucose.[39]

The trans- form can undergo photoisomerization to the cis- form when exposed to ultraviolet irradiation.[40][41]

Resveratrol photoisomerization

UV irradiation to cis-resveratrol induces further photochemical reaction, producing a fluorescent molecule named "Resveratrone".[42]

Trans-resveratrol in the powder form was found to be stable under "accelerated stability" conditions of 75% humidity and 40 °C in the presence of air.[43] The trans isomer is also stabilized by the presence of transport proteins.[44] Resveratrol content also was stable in the skins of grapes and pomace taken after fermentation and stored for a long period.[45] lH- and 13C-NMR data for the four most common forms of resveratrols are reported in literature.[39]

Biosynthesis

Resveratrol is produced in plants via the enzyme resveratrol synthase (stilbene synthase).[46][47] Its immediate precursor is a tetraketide derived from malonyl CoA and 4-coumaroyl CoA.[46][47] The latter is derived from phenylalanine.[48]

Biotransformation

The grapevine fungal pathogen Botrytis cinerea is able to oxidise resveratrol into metabolites showing attenuated antifungal activities. Those include the resveratrol dimers restrytisol A, B, and C, resveratrol trans-dehydrodimer, leachinol F, and pallidol.[49] The soil bacterium Bacillus cereus can be used to transform resveratrol into piceid (resveratrol 3-O-beta-D-glucoside).[50]

Adverse effects

Only a few human studies have been done to determine the adverse effects of resveratrol, all of them preliminary with small participant numbers. Adverse effects resulted mainly from long-term use (weeks or longer) and daily doses of 1000 mg or higher, causing nausea, stomach pain, flatulence, and diarrhea.[6] A review of 136 patients in seven studies who were given more than 500 mg for a month showed 25 cases of diarrhea, 8 cases of abdominal pain, 7 cases of nausea, and 5 cases of flatulence.[51] In a year-long preliminary clinical trial in people with Alzheimer's disease, the most frequent adverse effects were nausea and weight loss.[52] A 2018 review of resveratrol effects on blood pressure found that some people had increased frequency of bowel movements and loose stools.[16]

Occurrences

Plants

Resveratrol is a phytoalexin, a class of compounds produced by many plants when they are infected by pathogens or physically harmed by cutting, crushing, or ultraviolet radiation.[53]

Plants that synthesize resveratrol include knotweeds, pine trees including Scots pine and Eastern white pine, grape vines, raspberries, mulberries, peanut plants, cocoa bushes, and Vaccinium shrubs that produce berries, including blueberries, cranberries, and bilberries.[6][8][53]

Foods

The levels of resveratrol found in food varies considerably, even in the same food from season to season and batch to batch.[6]

Wine and grape juice
Beverage Resveratrol (mg/100 mL)[9]
meanrange
Red wine 0.270 — 2.78
Rosé wine 0.125.00×10−03 — 0.29
White wine 0.040.00 — 0.17
Sparkling wine 0.0098.00×10−03 — 1.00×10−02
Green grape juice 0.005080.00 — 1.00×10−02

Resveratrol concentrations in red wines average 1.9±1.7 mg trans-resveratrol/L (8.2±7.5 μM), ranging from nondetectable levels to 14.3 mg/L (62.7 μM) trans-resveratrol. Levels of cis-resveratrol follow the same trend as trans-resveratrol.[54]

In general, wines made from grapes of the Pinot noir and St. Laurent varieties showed the highest level of trans-resveratrol, though no wine or region can yet be said to produce wines with significantly higher concentrations than any other wine or region.[54] Champagne and vinegar also contain appreciable levels of resveratrol.[9]

Red wine contains between 0.2 and 5.8 mg/L, depending on the grape variety. White wine has much less because red wine is fermented with the skins, allowing the wine to extract the resveratrol, whereas white wine is fermented after the skin has been removed.[6] The composition of wine is different from that of grapes since the extraction of resveratrol from grapes depends on the duration of the skin contact, and the resveratrol 3-glucosides are in part hydrolysed, yielding both trans- and cis-resveratrol.[6][55]

Selected foods
Food Serving Total resveratrol (mg)[6]
Peanuts (raw) 1 cup (146 grams) 0.01 – 0.26
Peanut butter 1 cup (258 grams) 0.04 – 0.13
Red grapes 1 cup (160 grams) 0.24 – 1.25
Cocoa powder 1 cup (200 grams) 0.28 – 0.46

Ounce for ounce, peanuts have about 25% as much resveratrol as red wine.[6] Peanuts, especially sprouted peanuts, have a content similar to grapes in a range of 2.3 to 4.5 μg/g before sprouting, and after sprouting, in a range of 11.7 to 25.7 μg/g, depending on peanut cultivar.[9][53]

Mulberries (especially the skin) are a source of as much as 50 micrograms of resveratrol per gram dry weight.[56]

History

The first mention of resveratrol was in a Japanese article in 1939 by Michio Takaoka, who isolated it from Veratrum album, variety grandiflorum, and later, in 1963, from the roots of Japanese knotweed.[53][57][58][59] In 2004, Harvard University professor David Sinclair co-founded Sirtris Pharmaceuticals, the initial product of which was a resveratrol formulation.[60][61][62]

  • Dihydro-resveratrol
  • Epsilon-viniferin, Pallidol and Quadrangularin A three different resveratrol dimers
  • Elafibranor, a structurally related compound that acts as a dual PPARα/δ agonist
  • THSG, a glycoside compound found in He Shou Wu which is very similar to resveratrol.
  • Trans-diptoindonesin B, a resveratrol trimer
  • Hopeaphenol, a resveratrol tetramer
  • Oxyresveratrol, the aglycone of mulberroside A, a compound found in Morus alba, the white mulberry[63]
  • Piceatannol, an active metabolite of resveratrol found in red wine
  • Piceid, a resveratrol glucoside
  • Pterostilbene, a doubly methylated resveratrol
  • 4'-Methoxy-(E)-resveratrol 3-O-rutinoside, a compound found in the stem bark of Boswellia dalzielii[64]
  • Rhaponticin a glucoside of the stilbenoid rhapontigenin, found in rhubarb rhizomes

See also

References
  1. Camont L, Cottart CH, Rhayem Y, Nivet-Antoine V, Djelidi R, Collin F, Beaudeux JL, Bonnefont-Rousselot D; Cottart; Rhayem; Nivet-Antoine; Djelidi; Collin; Beaudeux; Bonnefont-Rousselot (February 2009). "Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions". Anal. Chim. Acta. 634 (1): 121–128. doi:10.1016/j.aca.2008.12.003. PMID 19154820.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. "Resveratrol MSDS on Fisher Scientific website". Archived from the original on 2012-11-03. Retrieved 2012-03-06.
  3. GHS: Sigma-Aldrich R5010
  4. Bechmann LP, Zahn D, Gieseler RK, Fingas CD, Marquitan G, Jochum C, Gerken G, Friedman SL, Canbay A; Zahn; Gieseler; Fingas; Marquitan; Jochum; Gerken; Friedman; Canbay (June 2009). "Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells". Hepatology Research. 39 (6): 601–608. doi:10.1111/j.1872-034X.2008.00485.x. PMC 2893585. PMID 19207580.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. Resveratrol MSDS on www.sigmaaldrich.com
  6. "Resveratrol". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis, OR. 11 June 2015. Retrieved 26 August 2019.
  7. Fremont, Lucie (January 2000). "Biological Effects of Resveratrol". Life Sciences. 66 (8): 663–673. doi:10.1016/S0024-3205(99)00410-5. PMID 10680575.
  8. Jasiński M, Jasińska L, Ogrodowczyk M; Jasińska; Ogrodowczyk (August 2013). "Resveratrol in prostate diseases - a short review". Cent European J Urol. 66 (2): 144–149. doi:10.5173/ceju.2013.02.art8. PMC 3936154. PMID 24579014.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. "Stilbenes-resveratrol in foods and beverages, version 3.6". Phenol-Explorer. 2016. Retrieved 13 May 2016.
  10. "Resveratrol". MedlinePlus, National Library of Medicine, US National Institutes of Health. 1 April 2019. Retrieved 22 September 2019.
  11. Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, et al. (2011). "What is new for an old molecule? Systematic review and recommendations on the use of resveratrol". PLOS ONE. 6 (6): e19881. Bibcode:2011PLoSO...619881V. doi:10.1371/journal.pone.0019881. PMC 3116821. PMID 21698226.
  12. Sahebkar A, Serban C, Ursoniu S, Wong ND, Muntner P, Graham IM, Mikhailidis DP, Rizzo M, Rysz J, Sperling LS, Lip GY, Banach M (2015). "Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials". Int. J. Cardiol. 189: 47–55. doi:10.1016/j.ijcard.2015.04.008. PMID 25885871.
  13. Warner, HR (2015). "NIA's Intervention Testing Program at 10 years of age". Age (Dordrecht, Netherlands). 37 (2): 22. doi:10.1007/s11357-015-9761-5. PMC 4344944. PMID 25726185.
  14. Singh AP, Singh R, Verma SS, Rai V, Kaschula CH, Maiti P, Gupta SC (September 2019). "Health benefits of resveratrol: Evidence from clinical studies". Med Res Rev. 39 (5): 1851–1891. doi:10.1002/med.21565. PMID 30741437. S2CID 73443806.
  15. Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, Tomás-Barberán FA, García-Conesa MT, Espín JC; Gonzálvez; Larrosa; Yáñez-Gascón; García-Almagro; Ruiz-Ros; Tomás-Barberán; García-Conesa; Espín (Jul 2013). "Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective". Annals of the New York Academy of Sciences. 1290 (1): 37–51. Bibcode:2013NYASA1290...37T. doi:10.1111/nyas.12150. PMID 23855464. S2CID 206223647.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. Fogacci F, Tocci G, Presta V, Fratter A, Borghi C, Cicero AF (January 2018). "Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials". Critical Reviews in Food Science and Nutrition. 58 (2): 1605–1618. doi:10.1080/10408398.2017.1422480. PMID 29359958. S2CID 30351462.
  17. Liu Y, Ma W, Zhang P, He S, Huang D; Ma; Zhang; He; Huang (March 2014). "Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials". Clinical Nutrition. 34 (1): 27–34. doi:10.1016/j.clnu.2014.03.009. PMID 24731650.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. Carter LG, D'Orazio JA, Pearson KJ; d'Orazio; Pearson (June 2014). "Resveratrol and cancer: focus on in vivo evidence". Endocr. Relat. Cancer. 21 (3): R209–R225. doi:10.1530/ERC-13-0171. PMC 4013237. PMID 24500760.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. Poulsen MM, Jørgensen JO, Jessen N, Richelsen B, Pedersen SB; Jørgensen; Jessen; Richelsen; Pedersen (Jul 2013). "Resveratrol in metabolic health: an overview of the current evidence and perspectives". Annals of the New York Academy of Sciences. 1290 (1): 74–82. Bibcode:2013NYASA1290...74P. doi:10.1111/nyas.12141. PMID 23855468. S2CID 206223623.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  20. Hausenblas HA, Schoulda JA, Smoliga JM; Schoulda; Smoliga (19 August 2014). "Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis". Molecular Nutrition & Food Research. 59 (1): 147–159. doi:10.1002/mnfr.201400173. PMID 25138371.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  21. De Ligt, M; Timmers, S; Schrauwen, P (2015). "Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852 (6): 1137–1144. doi:10.1016/j.bbadis.2014.11.012. PMID 25446988.
  22. Hausenblas HA, Schoulda JA, Smoliga JM (2015). "Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis". Mol Nutr Food Res. 59 (1): 147–159. doi:10.1002/mnfr.201400173. PMID 25138371.
  23. Zhu, Xiangyun; Wu, Chunhua; Qiu, Shanhu; Yuan, Xuelu; Li, Ling (22 September 2017). "Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis". Nutrition & Metabolism. 14 (1): 60. doi:10.1186/s12986-017-0217-z. ISSN 1743-7075. PMC 5610395. PMID 29018489.
  24. Mousavi, S. M.; Milajerdi, A.; Sheikhi, A.; Kord‐Varkaneh, H.; Feinle‐Bisset, C.; Larijani, B.; Esmaillzadeh, A. (2019). "Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta-analysis of randomized controlled trials". Obesity Reviews. 20 (3): 487–498. doi:10.1111/obr.12775. PMID 30515938. S2CID 54563469.
  25. Asgary, Sedigheh; Karimi, Raheleh; Momtaz, Saeideh; Naseri, Rozita; Farzaei, Mohammad Hosein (1 June 2019). "Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis". Reviews in Endocrine and Metabolic Disorders. 20 (2): 173–186. doi:10.1007/s11154-019-09494-z. PMID 31065943. S2CID 146806930.
  26. Koushki, Mehdi; Dashatan, Nasrin Amiri; Meshkani, Reza (July 2018). "Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials". Clinical Therapeutics. 40 (7): 1180–1192.e5. doi:10.1016/j.clinthera.2018.05.015. PMID 30017172. S2CID 51677307.
  27. Marx, Wolfgang; Kelly, Jaimon T.; Marshall, Skye; Cutajar, Jennifer; Annois, Brigitte; Pipingas, Andrew; Tierney, Audrey; Itsiopoulos, Catherine (1 June 2018). "Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials". Nutrition Reviews. 76 (6): 432–443. doi:10.1093/nutrit/nuy010. hdl:10072/389251. PMID 29596658. S2CID 4472410.
  28. Jeyaraman MM, Al-Yousif NS, Singh Mann A, Dolinsky VW, Rabbani R, Zarychanski R, Abou-Setta AM (January 2020). "Resveratrol for adults with type 2 diabetes mellitus". Cochrane Database Syst Rev. 1: CD011919. doi:10.1002/14651858.CD011919.pub2. PMC 6984411. PMID 31978258.
  29. Asis, Marzieh; Hemmati, Niloufar; Moradi, Sajjad; Nagulapalli Venkata, Kalyan C.; Mohammadi, Elham; Farzaei, Mohammad Hosein; Bishayee, Anupam (December 2019). "Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta‐analysis". Annals of the New York Academy of Sciences. 1457 (1): 92–103. Bibcode:2019NYASA1457...92A. doi:10.1111/nyas.14226. PMID 31490554. S2CID 201846615.
  30. Baell, J; Walters, MA (25 September 2014). "Chemistry: Chemical con artists foil drug discovery". Nature. 513 (7519): 481–483. Bibcode:2014Natur.513..481B. doi:10.1038/513481a. PMID 25254460.
  31. Ingólfsson, HI; Thakur, P; Herold, KF; Hobart, EA; Ramsey, NB; Periole, X; de Jong, DH; Zwama, M; Yilmaz, D; Hall, K; Maretzky, T; Hemmings HC, Jr; Blobel, C; Marrink, SJ; Koçer, A; Sack, JT; Andersen, OS (15 August 2014). "Phytochemicals perturb membranes and promiscuously alter protein function". ACS Chemical Biology. 9 (8): 1788–1798. doi:10.1021/cb500086e. PMC 4136704. PMID 24901212.
  32. Vang, O (August 2015). "Resveratrol: challenges in analyzing its biological effects". Annals of the New York Academy of Sciences. 1348 (1): 161–170. Bibcode:2015NYASA1348..161V. doi:10.1111/nyas.12879. PMID 26315294. S2CID 27108183.
  33. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK; Hsieh; Delegge; Oatis Jr; Walle (December 2004). "High absorption but very low bioavailability of oral resveratrol in humans". Drug Metab. Dispos. 32 (12): 1377–1382. doi:10.1124/dmd.104.000885. PMID 15333514. S2CID 10020092.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  34. Luca SV, Macovei I, Bujor A, Trifan A (2020). "Bioactivity of dietary polyphenols: The role of metabolites". Critical Reviews in Food Science and Nutrition. 60 (4): 626–659. doi:10.1080/10408398.2018.1546669. PMID 30614249. S2CID 58651581.
  35. Baur JA, Sinclair DA (2006). "Therapeutic potential of resveratrol: the in vivo evidence". Nature Reviews Drug Discovery. 5 (6): 493–506. doi:10.1038/nrd2060. PMID 16732220. S2CID 36628503.
  36. Sharan S, Nagar S; Nagar (2013). "Pulmonary metabolism of resveratrol: In vitro and in vivo evidence". Drug Metabolism and Disposition. 41 (5): 1163–1169. doi:10.1124/dmd.113.051326. PMC 3629805. PMID 23474649.
  37. Chimento A, De Amicis F, Sirianni R, Pezzi V (2019). "Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol". International Journal of Molecular Sciences. 20 (6): 1381. doi:10.3390/ijms20061381. PMC 6471659. PMID 30893846.
  38. Gambini J, Inglés M, Olaso G, Borras C (2015). "Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans". Oxidative Medicine and Cellular Longevity. 2015: 837042. doi:10.1155/2015/837042. PMC 4499410. PMID 26221416.
  39. Mattivi F, Reniero F, Korhammer S; Reniero; Korhammer (1995). "Isolation, characterization, and evolution in red wine vinification of resveratrol monomers". Journal of Agricultural and Food Chemistry. 43 (7): 1820–1823. doi:10.1021/jf00055a013.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  40. Lamuela-Raventos RM, Romero-Perez AI, Waterhouse AL, de la Torre-Boronat MC; Romero-Perez; Waterhouse; de la Torre-Boronat (1995). "Direct HPLC Analysis of cis- and trans-Resveratrol and Piceid Isomers in Spanish Red Vitis vinifera Wines". Journal of Agricultural and Food Chemistry. 43 (2): 281–283. doi:10.1021/jf00050a003.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  41. Resveratrol Photoisomerization: An Integrative Guided-Inquiry Experiment Elyse Bernard, Philip Britz-McKibbin, Nicholas Gernigon Vol. 84 No. 7 July 2007 Journal of Chemical Education 1159.
  42. Yang I, Kim E, Kang J, Han H, Sul S, Park SB, Kim SK; Kim; Kang; Han; Sul; Park; Kim (2012). "Photochemical generation of a new, highly fluorescent compound from non-fluorescent resveratrol". Chemical Communications. 48 (32): 3839–3841. doi:10.1039/C2CC30940H. PMID 22436889.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  43. Prokop J, Abrman P, Seligson AL, Sovak M; Abrman; Seligson; Sovak (2006). "Resveratrol and its glycon piceid are stable polyphenols". J Med Food. 9 (1): 11–14. doi:10.1089/jmf.2006.9.11. PMID 16579722.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  44. Pantusa M, Bartucci R, Rizzuti B; Bartucci; Rizzuti (2014). "Stability of trans-resveratrol associated with transport proteins". J Agric Food Chem. 62 (19): 4384–4391. doi:10.1021/jf405584a. PMID 24773207.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  45. Bertelli AA, Gozzini A, Stradi R, Stella S, Bertelli A; Gozzini; Stradi; Stella; Bertelli (1998). "Stability of resveratrol over time and in the various stages of grape transformation". Drugs Exp Clin Res. 24 (4): 207–211. PMID 10051967.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  46. Valletta, Alessio; Iozia, Lorenzo Maria; Leonelli, Francesca (January 2021). "Impact of Environmental Factors on Stilbene Biosynthesis". Plants. 10 (1): 90. doi:10.3390/plants10010090. PMC 7823792. PMID 33406721.
  47. Dubrovina, A. S.; Kiselev, K. V. (October 2017). "Regulation of stilbene biosynthesis in plants". Planta. 246 (4): 597–623. doi:10.1007/s00425-017-2730-8. ISSN 0032-0935. PMID 28685295. S2CID 4015467.
  48. Wang, Chuanhong; Zhi, Shuang; Liu, Changying; Xu, Fengxiang; Zhao, Aichun; Wang, Xiling; Ren, Yanhong; Li, Zhengang; Yu, Maode (2017). "Characterization of Stilbene Synthase Genes in Mulberry (Morus atropurpurea) and Metabolic Engineering for the Production of Resveratrol in Escherichia coli". Journal of Agricultural and Food Chemistry. 65 (8): 1659–1668. doi:10.1021/acs.jafc.6b05212. PMID 28168876.
  49. Cichewicz RH, Kouzi SA, Hamann MT; Kouzi; Hamann (January 2000). "Dimerization of resveratrol by the grapevine pathogen Botrytis cinerea". J. Nat. Prod. 63 (1): 29–33. doi:10.1021/np990266n. PMID 10650073.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  50. Cichewicz RH, Kouzi SA; Kouzi (October 1998). "Biotransformation of resveratrol to piceid by Bacillus cereus". J. Nat. Prod. 61 (10): 1313–1314. doi:10.1021/np980139b. PMID 9784180.
  51. Cottart C, Nivet-Antoine V, Beaudeux J (2014). "Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans". Molecular Nutrition & Food Research. 58 (1): 7–21. doi:10.1002/mnfr.201200589. PMID 23740855.
  52. Ahmed, T; Javed, S; Javed, S; Tariq, A; Šamec, D; Tejada, S; Nabavi, SF; Braidy, N; Nabavi, SM (May 2017). "Resveratrol and Alzheimer's Disease: Mechanistic Insights". Molecular Neurobiology. 54 (4): 2622–2635. doi:10.1007/s12035-016-9839-9. PMID 26993301. S2CID 22451655.
  53. Sales, JM; Resurreccion, AV (2014). "Resveratrol in peanuts". Critical Reviews in Food Science and Nutrition. 54 (6): 734–770. doi:10.1080/10408398.2011.606928. PMID 24345046. S2CID 13183809.
  54. Stervbo U, Vang O, Bonnesen C; Vang; Bonnesen (2007). "A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine". Food Chemistry. 101 (2): 449–457. doi:10.1016/j.foodchem.2006.01.047.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  55. Naiker, M.; Anderson, S.; Johnson, J. B.; Mani, J. S.; Wakeling, L.; Bowry, V. (2020-07-21). "Loss of trans ‐resveratrol during storage and ageing of red wines". Australian Journal of Grape and Wine Research. 26 (4): 385–387. doi:10.1111/ajgw.12449. ISSN 1322-7130. S2CID 225590316.
  56. Stewart JR, Artime MC, O'Brian CA; Artime; O'Brian (July 2003). "Resveratrol: a candidate nutritional substance for prostate cancer prevention". J. Nutr. 133 (7 Suppl): 2440S–2443S. doi:10.1093/jn/133.7.2440S. PMID 12840221.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  57. Takaoka M (1939). "Resveratrol, a new phenolic compound, from Veratrum grandiflorum". Journal of the Chemical Society of Japan. 60 (11): 1090–1100. doi:10.1246/nikkashi1921.60.1090.
  58. Takaoka, Michio (1940). "The Phenolic Substances of White Hellebore (Veratrum Grandiflorum Loes. Fill). V". Nippon Kagaku Kaishi. 61 (10): 1067–1069. doi:10.1246/nikkashi1921.61.1067.
  59. Nonomura; Kanagawa (1963). "Chemical constituents of Polygonaceous plants. I. studies on the components of Ko-jo-kon. (Polygonum cuspidatum SIEB et ZUCC)". Yakugaku Zasshi. 83 (10): 988–990. doi:10.1248/yakushi1947.83.10_988.
  60. Rimas A (2006-12-11). "His research targets the aging process". The Boston Globe.
  61. Stipp D (2007-01-19). "Can red wine help you live forever?". Fortune magazine.
  62. Weintraub A (2009-07-29). "Resveratrol: The Hard Sell on Anti-Aging". Bloomberg Businessweek.
  63. Kim JK, Kim M, Cho SG, Kim MK, Kim SW, Lim YH; Kim; Cho; Kim; Kim; Lim (June 2010). "Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition". J. Ind. Microbiol. Biotechnol. 37 (6): 631–637. doi:10.1007/s10295-010-0722-9. PMID 20411402. S2CID 21236818.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  64. Alemika Taiwo E, Onawunmi Grace O and Olugbade Tiwalade O, Antibacterial phenolics from Boswellia dalzielii. Nigerian Journal of Natural Products and Medicines, 2006
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.